- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Boehringer’s medical information letter and a “scientific” congress stand were found to promote Pradaxa (dabigatran) for unlicensed indications and include misleading/disparaging statements,…
Anonymous GP alleged he was misled into providing a letter for a rep’s disciplinary defence, believing it was for market research. Panel…
A personalised COPD “NHS challenge” report carried a consultant’s name beside the AstraZeneca logo and was emailed onwards, implying her authorship/endorsement without…
Anonymous complaint alleged Pfizer sponsored a Saturday meeting at a luxury golf and spa resort to entice doctors. Pfizer denied involvement and…
Pfizer (post-Wyeth merger) was found in breach after a menopause patient website used outdated WHI 2004 data and prominent “-6” graphics implying…
A Sanofi-Aventis rep asked a hospital consultant to countersign a shotgun licence renewal form during/around product discussion in a cardiology reception area.…
A Symbicort Turbohaler leavepiece compared lung deposition with “a pressurised MDI” without qualifying that some MDIs have much higher deposition. PMCPA found…
Indivior did not publish its 2017 UK transfers of value on the ABPI central platform by the June 2018 deadline. PMCPA found…
A third-party agency published Respimat e-learning before certification and emailed pharmacists without approval. The email lacked prescribing information and other required statements,…
AstraZeneca admitted a Fluenz Tetra website/Q&A claim about “no laboratory-confirmed” LAIV transmission could not be substantiated by cited references. PMCPA ruled it…
Anonymous employee alleged “huge bonuses” and incentives for field staff. Panel initially found breach of 15.7 and 9.1 for a 50–60% bonus…
Genus described APO-go nurse advisors as “Pd specialist” in a journal ad and implied PD nurse specialist status in a services booklet.…
A GP challenged a Yasmin journal ad suggesting benefits for acne, fluid retention, hirsutism and premenstrual symptoms. The Panel found the overall…
Baxter’s FEIBA materials claimed “Up to 85% reduction in bleed frequency”. PMCPA ruled the figure cherry-picked and didn’t reflect the full contemporaneous…
GP alleged Daily Mail coverage promoted Victoza (liraglutide) for weight loss and made exaggerated claims. Panel found Novo Nordisk’s meeting/materials did not…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.